Overview

A Study of Avonex to Determine the Effects of Dose Titration on the Incidence of Flu Like Symptoms in Healthy Volunteers

Status:
Completed
Trial end date:
2010-10-23
Target enrollment:
Participant gender:
Summary
The primary objective of the study is to determine whether titration of Avonex reduces the severity of flu-like symptoms (FLS). Secondary objectives of this study are to determine whether titration of Avonex reduces the incidence of FLS and to evaluate the overall safety and tolerability of Avonex intramuscular (IM) injections.
Phase:
Phase 1
Details
Lead Sponsor:
Biogen
Treatments:
Interferon beta-1a